Scientists map the portal to the cell's nucleus
In a collaborative effort described in the March 14th Nature, a team of scientists from the Center for Infectious Disease Research (CIDR), The Rockefeller University, and other partnering institutions have delineated the architecture of the nuclear pore complex in yeast cells. The researchers hope the mapping of this molecular structure will enable new studies of how the nuclear portal functions normally, how defects in it lead to diseases such as cancer and how viruses and other pathogens exploit the complex to their own advantage.
The pore complex contains 552 component proteins, called nucleoporins, and scientists hadn’t previously known how they all fit together. It took a combination of approaches to assemble a comprehensive map of these pieces. The team was able to determine a high-resolution structure for the complex, including type and amount of each protein and their individual contributions to the overall complex. The biological blueprint they uncovered shares principles sometimes seen on a much larger scale in concrete, steel, and wire.
Initially, John Aitchison (now at CIDR), Mike Rout and Brian Chait (both at Rockefeller) began mapping this ancient structure more than 20 years ago, knowing the project could well span decades since the target of their curiosity is not easily defined.
More than a third of the pore complex can move about, and this flexibility, along with the structure’s immense size and the constant stream of traffic passing through it, meant that no single approach to mapping it would work. “In the end, we used everything we could lay our hands on, brought the results together, and integrated them into a single structure,” says Chait, who is Rockefeller’s Camille and Henry Dreyfus Professor.
This data allowed them to visualize the anatomy of many of the individual pore components and to place them all within the pore complex. They uncovered a complicated ringed structure containing rigid, diagonal columns and flexible connectors that evoke the towers and cables of human-made structures like the Golden Gate Bridge.
A map showing how the 552 pieces of the pore complex fit together could inform research into numerous diseases.
More about the pore
Like an island nation, the nucleus of a cell has a transportation problem. Evolution has enclosed it with a double membrane, the nuclear envelope, which protects DNA but also cuts it off from the rest of the cell. Nature’s solution is a massive—by molecular standards—cylindrical configuration known as the nuclear pore complex, through which imports and exports travel, connecting the bulk of the cell with its headquarters.
The pore complex first emerged when single-celled organisms—the only living things at the time—acquired special compartments containing organ-like structures, including the nucleus, which houses the cell’s genetic code.
It serves not only as a conduit to and from the nucleus, but also as a checkpoint regulating what passes in and out. Genetic instructions transcribed into RNA are allowed to exit, for example, while proteins needed inside the nucleus may enter. Other things, such as viruses bent on taking over the cell, are kept at bay.
A new starting point
When it comes to the pore complex, yeast has a considerable amount in common with us. When the team compared their data with structural findings from human pore complexes, they found similar elements arranged somewhat differently. The resemblance suggests the yeast pore complex could be useful for further research relevant to humans.
And there’s a lot of such research to be done. Defects in the pore complex and its components have been linked to a host of diseases, including autoimmune disorders and cancer; meanwhile, viruses have evolved ways to sneak past it altogether. But the details of these malfunctions and blind spots are often obscure.
The new structure may help. With it, the team found they could map sites that are altered in some cancers—evidence, they say, that the yeast pore complex can be used to test how factors like stress, drugs, or mutations change the human structure, and so aiding efforts to understand and treat disease.